The new technology behind Pfizer’s and Moderna’s coronavirus vaccines could be used to prevent everything from heart disease to cancer, experts say. The breakthrough vaccine ‘platform’ they use transforms the body into a virus-zapping vaccine factory and could be retooled to run interference on other diseases and speed the development of shots to prevent future … Read more
How does Moderna vaccine work and which countries are first in line for it? As new Covid-19 jab is said to be 94.5% effective, we answer your questions about the latest development US spent $1bn on vaccine and is promised 20million doses by the end of year UK ministers were concerned would take too long … Read more
BREAKING NEWS: Moderna CEO says the firm could get emergency FDA approval for a vaccine in December if trial results results expected this month are successful Moderna Inc’s CEO says the company is expecting the interim results of its coronavirus vaccine trial this month If the results are positive, along with the two months of … Read more
Moderna Inc says it expects to know if its experimental coronavirus vaccine is effective by next month. In an earnings call on Thursday, the Cambridge, Massachusetts-based company says interim Phase III results are due in November. The company has completed enrollment of 30,000 volunteers for the final stage, with a more diverse group – including … Read more
As scientists race to develop a coronavirus vaccine to bring the world back to normal, MailOnline has taken a look at the prospective candidates. Vaccine trials were halted on Wednesday but it may still be ready this year The Oxford Vaccine When will it be ready?: The end of 2020/ early 2021. Despite the trials … Read more
Moderna Inc announced on Thursday that it has completed enrollment of 30,000 volunteers for the final stage of its coronavirus vaccine trial. Additionally, the Massachusetts-based company says its group is more diverse and that more than 5,000 volunteers have already received their second of two jabs. The reveal indicates that the company is not far … Read more
US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency. Pfizer, the other American company currently carrying out Phase 3 trials in the US, followed suit a short time later … Read more
Moderna has dosed its first set of patients in a second phase clinical trial for its coronavirus vaccine, the company announced on Friday. Vaccines are a top-priority for health officials and biotech firms in the battle against coronavirus, as a shot to prevent infection would finally make it safe for people to return to work … Read more
Moderna’s experimental COVID-19 vaccine produced antibodies that could ‘neutralize’ the new coronavirus in patients in a small early stage clinical trial, the company announced Monday, sending its shares up 25 percent. The levels of the antibodies were similar to those in blood samples of people who have recovered from COVID-19, early results from the study … Read more